Chemours (NYSE: CC) reported Q2 EPS of $1.71, $0.12 better than the analyst estimate of $1.59. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.82 billion.

For earnings history and earnings-related data on Chemours (CC) click here.